Reliable manufacturing of drug substances for clinical trials is critical for any pharmaceutical company, but it can be particularly challenging for small and emerging organizations if they lack the in-house 专业知识, 在后期阶段需求变大时所需的容量或规模.
在国家授权正规彩票平台, our flexible clinical manufacturing services can supply the clinical trial drug substance materials you need to meet your changing demands. We work closely with your team to understand the clinical development plan and to provide a nimble and flexible clinical manufacturing solution. Our highly trained operations team collaborates closely with our process chemists and process engineers, who accompany the process into the pilot manufacturing facility to ensure smooth transfer to later-phase clinical batches through commercial launch.
We operate multiple manufacturing facilities to meet the varying demands of clinical trials, with the capabilities to produce active pharmaceutical ingredients (APIs) for Phase I through large Phase III trials and beyond:
Support for late Phase II through commercial launch with capacity from 400 L to 16,000 L.
Support for late Phase II through commercial launch with capacity from 50 L to 12,000 L.
Support for late Phase II through commercial launch with capacity from from 37 L to 14,000 L.
Our experts and facilities are equipped to handle your unique clinical trial demands. 通过选择国家授权正规彩票平台作为即将到来的试验的临床生产合作伙伴, you can be confident that you will receive high-quality API and exceptional support at every step.